Patents by Inventor Jitka V. Olander

Jitka V. Olander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5036003
    Abstract: A method of producing antibodies against vascular permeability factor (VPF) is disclosed which comprises immunizing a host animal with a peptide having an amino acid sequence as follows: ##STR1## or a fragment of said peptide containing an antigenic determinant of VPF.
    Type: Grant
    Filed: September 2, 1988
    Date of Patent: July 30, 1991
    Assignee: Monsanto Company
    Inventors: Jitka V. Olander, Daniel T. Connolly, Steven P. Adams, Joseph Feder
  • Patent number: 4891312
    Abstract: A monoclonal antibody is disclosed which is specific for human colon fibroblast-derived tissue plasminogen activator (t-PA), and which is useful for immunoaffinity chromatography purification of t-PA and determination of t-PA in a biological sample.
    Type: Grant
    Filed: January 6, 1989
    Date of Patent: January 2, 1990
    Assignee: Monsanto Company
    Inventors: Jon P. Schaumann, Jitka V. Olander, Nicholaos K. Harakas, Joseph Feder
  • Patent number: 4889922
    Abstract: A monoclonal antibody is disclosed which is specific for human colon fibroblast-derived tissue plasminogen activator (t-PA), and which is useful for immunoaffinity chromatography purification of t-PA and determination of t-PA in a biological sample.
    Type: Grant
    Filed: January 6, 1989
    Date of Patent: December 26, 1989
    Assignee: Monsanto Co.
    Inventors: Jon P. Schaumann, Jitka V. Olander, Nicholaos K. Hrakas, Joseph Feder
  • Patent number: 4833085
    Abstract: A monoclonal antibody is disclosed which is specific for human colon fibroblast-derived tissue plasminogen activator (t-PA), and which is useful for immunoaffinity chromatography purification of t-PA and determination of t-PA in a biological sample.
    Type: Grant
    Filed: August 13, 1986
    Date of Patent: May 23, 1989
    Assignee: Monsanto Company
    Inventors: Jon P. Schaumann, Jitka V. Olander, Nicholaos K. Harakas, Joseph Feder
  • Patent number: 4533496
    Abstract: Monoclonal antibodies are isolated from spent culture medium of the in vitro growth of hybridoma cells by treating said spent cell culture medium or a concentrate thereof with a water-insoluble, cross-linked polyelectrolyte copolymer.
    Type: Grant
    Filed: May 8, 1984
    Date of Patent: August 6, 1985
    Assignee: Monsanto Company
    Inventors: Charles Lewis, Jr., Jitka V. Olander, William R. Tolbert